Armata Pharmaceuticals, Inc. Common Stock
$4.40
Market Cap
$163.60M
Shares Outstanding
37.2M
Primary Exchange
XASE
Currency
USD
Type
CS
IPO Date
May 27, 1994
Round Lot
100
Locale
US
Day Open
$5.24
Day High
$5.35
Day Low
$4.23
Volume
650.2K
VWAP
$4.57
Prev Close
$5.55
Transactions
--
Acc. Volume
--
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Armata Pharmaceuticals, Inc. Common Stock (ARMP) closed the 2026-09-15 session at $4.40, down 20.72% versus the previous close (-1.15). The stock opened at $5.24 and traded between $4.23 and $5.35 during that session. Session trading volume was 650K shares. The volume-weighted average price (VWAP) is $4.57.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Armata Pharmaceuticals, Inc. Common Stock has a market capitalization of $163.6 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. ARMP is listed on the XASE exchange. The company employs approximately 61 people. Armata Pharmaceuticals, Inc. Common Stock is headquartered in LOS ANGELES, CA. The recorded listing date is 1994-05-27.
On this page you can find market ARMP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.